Nectar Lifesciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Dec' 23	Sep' 23	Jun' 23	Mar' 23	Dec' 22

Sales

452.17

397.96

394.12

388.81

344.13

Operating profit

42.19

26.86

35.54

19.77

1.45

Interest

24.84

20.52

17.62

19.66

17.46

Gross profit

17.83

16.95

18.39

18.04

-2.78

EPS (Rs)

0.07

0.05

0.08

0.24

-0.41

Other income

0.48

10.61

0.47

17.92

13.24

Stock adjustment

-14.96

31.63

-4.49

-42.02

22.89

Raw material

342.32

256.16

283.65

332.55

247.51

Power and fuel

-

-

-

-

-

Employee expenses

21.62

20.31

18.80

20.31

19.71

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

60.99

63.00

60.62

58.20

52.56

Provisions made

-

-

-

-

-

Depreciation

15.37

15.31

15.33

14.85

14.78

Taxation

0.89

0.63

1.24

-2.17

-8.27

Net profit / loss

1.57

1.02

1.82

5.36

-9.29

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

22.43

22.43

22.43

22.43

22.43

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

9.33

6.75

9.02

5.09

0.42

GPM (%)

3.94

4.15

4.66

4.43

-.78

NPM (%)

0.35

0.25

0.46

1.32

-2.60